(Q82997073)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

F Borgström

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Carlsson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Sintonen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Boonen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

P Haentjens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R Burge

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

O Johnell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

B Jönsson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J A Kanis

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

29 March 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

Osteoporosis International

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

996-1007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00198-006-0094-1

18 January 2020

exact match

0 references

cites work

The components of excess mortality after hip fracture

1 reference

12 December 2020

Cost-effectiveness of bisoprolol in chronic heart failure

1 reference

12 December 2020

Mortality after osteoporotic fractures

1 reference

12 December 2020

The burden of osteoporotic fractures: a method for setting intervention thresholds

1 reference

12 December 2020

The cost utility of bisphosphonate treatment in established osteoporosis

1 reference

12 December 2020

A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture.

1 reference

12 December 2020

Preference for fractures and other glucocorticoid-associated adverse effects among rheumatoid arthritis patients.

1 reference

12 December 2020

Mortality after all major types of osteoporotic fracture in men and women: an observational study.

1 reference

12 December 2020

The hospital burden of vertebral fracture in Europe: a study of national register sources.

1 reference

12 December 2020

Cost-effectiveness of preventing hip fracture in the general female population.

1 reference

12 December 2020

The cost of a hip fracture. Estimates for 1,709 patients in Sweden

1 reference

12 December 2020

Epidemiology and outcomes of osteoporotic fractures

1 reference

12 December 2020

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

12 December 2020

What is the true mortality of hip fractures?

1 reference

12 December 2020

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

12 December 2020

Pharmacoeconomic analysis of osteoporosis treatment with risedronate.

1 reference

12 December 2020

Hip fractures in Finland between 1970 and 1997 and predictions for the future

1 reference

12 December 2020

Population-based study of survival after osteoporotic fractures

1 reference

12 December 2020

Modeling valuations for EuroQol health states

1 reference

12 December 2020

1 reference

12 December 2020

Lifetime risk of hip fractures is underestimated

1 reference

12 December 2020

Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

1 reference

12 December 2020

A meta-analysis of previous fracture and subsequent fracture risk

1 reference

12 December 2020

Risk of Mortality Following Clinical Fractures

1 reference

12 December 2020

Cost-effectiveness of fracture prevention in established osteoporosis.

1 reference

12 December 2020

Markov models in medical decision making: a practical guide.

1 reference

12 December 2020

A computer model to analyze the cost-effectiveness of hormone replacement therapy

1 reference

12 December 2020

Costs Induced by Hip Fractures: A Prospective Controlled Study in Belgium

1 reference

12 December 2020

Requirements for DXA for the management of osteoporosis in Europe

1 reference

12 December 2020

The risk and burden of vertebral fractures in Sweden

1 reference

12 December 2020

The variable incidence of hip fracture in southern Europe: the MEDOS Study

1 reference

12 December 2020

Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden.

1 reference

12 December 2020

Treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

1 reference

12 December 2020

Impact of hip and vertebral fractures on quality-adjusted life years.

1 reference

12 December 2020

[What is an efficient health technology in Spain?]

1 reference

12 December 2020

Long-term risk of osteoporotic fracture in Malmö.

1 reference

12 December 2020

The psychometric properties of patient preferences in osteoporosis.

1 reference

12 December 2020

A systematic review of health state utility values for osteoporosis-related conditions

1 reference

12 December 2020

NICE: faster access to modern treatments? Analysis of guidance on health technologies

1 reference

12 December 2020

Economic assessment based on a clinical study of risedronate. Fracture prevention in elderly women with osteoporosis is cost-effective

1 reference

12 December 2020

Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis

1 reference

12 December 2020

Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions

1 reference

12 December 2020

Economic analysis of health technologies and programmes. A Spanish proposal for methodological standardisation

1 reference

12 December 2020

Cost-effectiveness of alendronate treatment of osteoporosis in Denmark. An economic evaluation based on the Fracture Intervention Trial

1 reference

12 December 2020

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

12 December 2020

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery

1 reference

12 December 2020

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

1 reference

12 December 2020

Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis

1 reference

12 December 2020

Updated data on proximal femur bone mineral levels of US adults

1 reference

12 December 2020

Intervention thresholds for osteoporosis

1 reference

12 December 2020

Cost effectiveness of alendronate (fosamax) for the treatment of osteoporosis and prevention of fractures

1 reference

12 December 2020

Economic evaluation of interventions for osteoporosis

1 reference

12 December 2020

10.1007/S00198-006-0094-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16570118%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference